Stay updated on Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe page shows a revision label updated from v3.5.4 to v3.5.5, indicating a new revision version of the content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new site release. This update is metadata only and does not change the study text, results, or other user-facing content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer/update marker was incremented from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting an interface/version change rather than any change to the underlying study record.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Idiopathic Pulmonary Fibrosis and Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedThe keyword tag 'Interstitial lung disease 2' was removed from the page metadata; core trial details remain unchanged.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This appears to be a minor template update with no impact on trial details.SummaryDifference0.0%

Stay in the know with updates to Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belumosudil for Idiopathic Pulmonary Fibrosis Clinical Trial page.